Home/Filings/4/0001209191-21-053983
4//SEC Filing

Lemus David 4

Accession 0001209191-21-053983

CIK 0000850261other

Filed

Aug 29, 8:00 PM ET

Accepted

Aug 30, 8:13 PM ET

Size

5.6 KB

Accession

0001209191-21-053983

Insider Transaction Report

Form 4
Period: 2021-08-30
Lemus David
Director
Transactions
  • Award

    Stock option (right to buy)

    2021-08-30+250,000250,000 total
    Exercise: $8.86Exp: 2031-08-30Common Stock (250,000 underlying)
Footnotes (1)
  • [F1]1/48th of the original number of shares subject to this option shall vest and become exercisable on September 30, 2021, and 1/48th of the original number of shares subject to the option shall vest following each one month of service thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date.

Issuer

Sorrento Therapeutics, Inc.

CIK 0000850261

Entity typeother

Related Parties

1
  • filerCIK 0001717972

Filing Metadata

Form type
4
Filed
Aug 29, 8:00 PM ET
Accepted
Aug 30, 8:13 PM ET
Size
5.6 KB